Lena A. Stabell
Bergen, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Cytokine changes during a 12-month pragmatic randomized trial in schizophrenia spectrum disorders comparing amisulpride, aripiprazole and olanzapine.
Journal: Psychiatry research
Published: December 23, 2025
Levels of and changes in psychosis symptoms and clinical insight: Exploring the impact of differential antipsychotic mechanisms.
Journal: Psychiatry research
Published: April 01, 2025
Prednisolone add-on in early phase schizophrenia: A randomized, double-blind, placebo-controlled pilot study.
Journal: Brain, behavior, & immunity - health
Published: January 27, 2025
Early warning signals observed in motor activity preceding mood state change in bipolar disorder.
Journal: Bipolar disorders
Published: April 19, 2024
Seroprevalence of SARS-CoV-2 antibodies in a prospective cohort of patients admitted to an acute psychiatric ward in Norway during the initial months of the COVID-19 pandemic.
Journal: Nordic journal of psychiatry
Published: December 01, 2023
Clinical insight among persons with schizophrenia spectrum disorders treated with amisulpride, aripiprazole or olanzapine: a semi-randomised trial.
Journal: BMC psychiatry
Published: January 17, 2023
Association between C-reactive protein levels and antipsychotic treatment during 12 months follow-up period after acute psychosis.
Journal: Schizophrenia research
Published: April 05, 2021
Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial.
Journal: The lancet. Psychiatry
Published: February 09, 2020
Predictors of treatment satisfaction in antipsychotic-naïve and previously medicated patients with acute-phase psychosis.
Journal: Nordic journal of psychiatry
Published: July 05, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026